Jobs
View more job listings or post a job
Gate Bioscience Director of Toxicology
Nura Bio Director of Toxicology
Nura Bio Vice President of CMC
MilliporeSigma Emerging Biotech Market Development Manager - San Fransisco
How Cancer LLC Social Media Digital Marketing Specialist  
How Cancer LLC Syndicated National Writer - Cancer 
University of California, Davis SCREENING SUPERVISOR
InnoAlliance Scientist/Sr Scientist of Bioanalysis & Biomarkers
Post a job

Symposium

[Free Online] Innovative Life Science Technologies in the Drug Development Toolbox: From Cancer Organoids and Biomarker Profiling to Label-Free Multiplex QES Assays


Speakers: Aihua Fu, NVIGEN; Emily Miyashita-Lin, Cellentia; Chaitanya Gupta, Probius; Joseph de Rutte, Partillion Bioscience; Andrew Chang, DeepSeq.AI; Xiaoxi Wei, X-Therma Inc.; Samuel Tia, Correlia Biosystems
Organizers: Shian Jiun Shih (Cellentia, Inc.), Aihua Fu (NVIGEN), Alex Yang (Vir Biotechnology)
Date: 2024-04-12
Time: 8:30-13:30 Pacific Time
Registration fee: 0
Location: Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2024-04-11  (it will close sooner if the seating cap is reached)

About the Topic

The abstract of this symposium:
The era of one-size-fits-all pharmaceuticals is fading. Today, the drug development landscape brims with groundbreaking modalities - from gene and cell therapies to mRNA and antibody-drug conjugates (ADCs) armed with radiotherapy. This transformative journey demands equally disruptive tools to streamline and accelerate research. Join us at this symposium as we explore the frontier of technology propelling the discovery of next-generation therapeutics. This symposium will showcase a diverse arsenal of tools designed to empower every stage of drug development. Topics include single-cell analysis, AI-based protein design, cancer organoids for drug screening, multiplex assays sans detecting agents, and sensitive NGS/multiomic biomarker profiling assays revealing previously hidden disease complexity. These advancements reflect the continuous pursuit of innovation, accelerating the quest for more effective, targeted, and ultimately, transformative therapeutic solutions.
 

Time (PT)

Topic

Speaker

8:30-8:40 am

PBSS Welcome and Introduction

Shichang Miao, PhD, PBSS

8:40-9:15 am

Novel Non-Invasive Organoid Platform from Cancer Patient Circulating Tumor Cells for Drug Screening and Monitoring

Emily Miyashita-Lin, Director, Cellentia

9:15-9:50 am

Expand Your Functional Toolkit: Nanovial Assays for Drug Discovery and Development

Joseph De Rutte, CEO and Co-founder, Partillion Bioscience

9:50-10:25 am

Evaluation of the PIXI™ Automated Platform for Rapid, Micro-volume PK Measurements

Samuel Tia, CSO and Co-founder, Correlia Biosystems

10:25-10:35 am

Break

-

10:35-11:10 am

Crack the Biomarker Code: Accelerate Drug Development with NVIGEN's Precision Medicine Biomarker Profiling Assays

Aihua Fu, CEO and Co-founder, NVIGEN

11:10-11:45 am

Simplifying Bio Analytical Assay Development: The Quantum Electrochemical Spectroscopy (QES) Approach

Chaitanya Gupta, CTO and Co-founder, Probius

11:45-12:20 pm

A Tale of a Golden Shovel in the Gold Rush: Next-Generation DMSO-Free & Serum-Free Biopreservation for Cell & Gene Therapies and Engineered Tissues Manufacturing And Processing

Xiaoxi (Sofie) Wei,CEO and Co-founder, X-Therma

12:20-12:55 pm

Unlocking the Potential of Explainable AI in Designing Functional Protein Libraries

Andrew Chang,CEO and Co-founder, DeepSeq AI

12:55-1:25 pm

Q&A and Panel discussion

All Speakers


2025-02-13, [Free Online] The Science and Stories of Promising Biotech Startups
2025-02-26, [In-Person] Demystifying Biopharma Business Development: Understanding the Process and Thriving as a BD Professional
2025-03-07, [In-Person] Clinical Trial Planning and Conduct: Fundamentals, Strategies and Best Practices
2025-03-27, [Free Online Workshop] Biotech Financing 101: from Angels, Government Agencies, Foundations and VCs
2025-04-01, [For vendors ONLY] Seattle PBSS Seminar Luncheon Vendor Show
2025-04-09, [In-Person] Cell Therapy Discovery and Development: Fundamentals, Strategies and Best Practices (jointly by PBSS and RAPS-SF)
2025-04-22, [Free Online Workshop] Career Transitions for Research Scientists: BD/Sales in CROs, CDMOs, and Lab Products & Instruments
2025-04-25, [In-Person] Drug Metabolism Fundamentals and Metabolite Identification
2025-05-05, [Free Online] Highlights of 2024 FDA Drug Approvals
2025-05-12, [In-Person] Preclinical Pharmacology Studies and Translational Medicine for Drug Discovery and Development
2025-06-02, [In-Person] Metabolism and Transport-mediated Drug-Drug Interaction: Current Practices, Regulatory Guidances, and Their Impact on Drug Development
©Pharmaceutical & BioScience Society, International; Last Modified: 2/12/2025; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Hypha Discovery Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
Allucent Experts bringing development innovation w/ClinPharm Modeling & Simulation deliverables to inform dose, study design, modeling+development strategies.
Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Submit a Text Ad